Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Key Pharmacy and Compounding Center

Key Pharmacy and Compounding Center Recalls

All product recalls associated with Key Pharmacy and Compounding Center.

Get alerts for this brand

Recall Summary

Total Recalls

79

Past Year

0

Class I (Serious)

0

Most Recent

Apr 2017

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 21–40 of 79 recalls

Iron Special Injection (Key Pharmacy) - Sterility Risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

CHOL/IN/ME(L)/B6 Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

TRI MIX Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Page 2 of 4Next

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Papaverine/Phent Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

DMPS Acid Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Folinic Acid Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Sodium Bicarb Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Hydroxo-B12 Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

PGE1/CPZ Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

TRI MIX Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

TRI MIX Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

PGE1 Injection (Key Pharmacy) – sterility risk (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

CO-Q-10 Oil (Key Pharmacy) – Sterility Concern (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Hydroxo-B12 Inhalation Solution (Key Pharmacy) – Sterility Concern (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Cyanocobalamin Injection (Key Pharmacy) – Sterility Concern (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Tri Mix Injection (Key Pharmacy) – Sterility Concern (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Testosterone Aqueous Injection (Key Pharmacy) – Sterility Concern (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Quad Mix Injection (Key Pharmacy) – Sterility Concern (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Tri Mix Injection (Key Pharmacy) – Sterility Concern (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center

Tri Mix Injection (Key Pharmacy) – Sterility Concern (2017)

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Class IIModerate

FDAApr 18, 2017Nationwide• Key Pharmacy and Compounding Center